Holen Sie sich die Stockscreener-App
6.02
3.97%
0.23
Schlusskurs vom Vortag:
$5.79
Offen:
$5.87
24-Stunden-Volumen:
42,464
Relative Volume:
0.96
Marktkapitalisierung:
$830.73M
Einnahmen:
$9.96M
Nettoeinkommen (Verlust:
$-199.33M
KGV:
-1.8064
EPS:
-3.3326
Netto-Cashflow:
$-93.38M
1W Leistung:
+9.06%
1M Leistung:
-2.75%
6M Leistung:
+104.76%
1J Leistung:
+238.20%
1-Tages-Spanne:
$5.87
$6.065
1-Wochen-Bereich:
$5.5903
$6.18
52-Wochen-Spanne:
$1.60
$6.4999
Inventiva Adr Stock (IVA) Company Profile
Vergleichen Sie IVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
5.97 | 805.16M | 9.96M | -199.33M | -93.38M | -3.3326 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.81 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
606.43 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.62 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
774.96 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.21 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-27 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | TD Cowen | Buy |
| 2024-11-12 | Eingeleitet | UBS | Neutral |
| 2023-10-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-19 | Hochstufung | Societe Generale | Sell → Buy |
| 2023-03-17 | Eingeleitet | Stifel | Buy |
| 2022-11-15 | Herabstufung | Societe Generale | Buy → Sell |
| 2021-03-08 | Herabstufung | Societe Generale | Buy → Sell |
| 2020-08-05 | Eingeleitet | ROTH Capital | Buy |
| 2020-08-04 | Eingeleitet | Guggenheim | Buy |
| 2020-08-04 | Eingeleitet | Stifel | Buy |
Alle ansehen
Inventiva Adr Aktie (IVA) Neueste Nachrichten
Inventiva Appoints Andrew Obenshain as Chief Executive Officer - GlobeNewswire Inc.
Inventiva (NASDAQ:IVA) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Inventiva SA Reports Progress and Challenges in 2025 - TipRanks
Inventiva (NASDAQ:IVA) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Inventiva (NASDAQ:IVA) Shares Gap UpHere's What Happened - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $14.83 Average Target Price from Analysts - Defense World
Inventiva (NASDAQ:IVA) Shares Gap DownTime to Sell? - MarketBeat
Brokerages Set Inventiva S.A. Sponsored ADR (NASDAQ:IVA) PT at $14.83 - MarketBeat
Inventiva (NASDAQ:IVA) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Sees Significant Growth in Short Interest - MarketBeat
Inventiva (IVA) to Release Quarterly Earnings on Thursday - Defense World
Inventiva (NASDAQ:IVA) Shares Gap Down – Should You Sell? - Defense World
Brokers Set Expectations for Inventiva FY2025 Earnings - MarketBeat
Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Increases By 188.0% - MarketBeat
Inventiva (NASDAQ:IVA) Shares Gap Up After Analyst Upgrade - MarketBeat
Inventiva (NASDAQ:IVA) Sees Large Volume Increase Following Analyst Upgrade - MarketBeat
Inventiva (NASDAQ:IVA) Earns Buy Rating from Analysts at HC Wainwright - Defense World
HC Wainwright Forecasts Inventiva FY2025 Earnings - Defense World
American Outdoor Brands Posts Downbeat Results, Joins Lululemon, Quanex Building And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Inventiva (NASDAQ:IVA) Shares Gap Up on Analyst Upgrade - Defense World
Inventiva (NASDAQ:IVA) Price Target Raised to $13.00 at Guggenheim - Defense World
Why Did Inventiva Stock Plunge 10.82%? - AInvest
Inventiva (NASDAQ:IVA) Shares Gap Down – Here’s What Happened - Defense World
Inventiva (NASDAQ:IVA) Trading Up 4.3%Should You Buy? - MarketBeat
Inventiva (NASDAQ:IVA) Earns Overweight Rating from Analysts at Piper Sandler - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $10.40 Average Price Target from Brokerages - Defense World
How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79% - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Inventiva (NASDAQ:IVA) Trading 4.3% Higher – What’s Next? - Defense World
Wealth Enhancement Advisory Services LLC Acquires New Shares in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) - Defense World
Rokmaster Resources (CVE:RKR) Stock Price Up 71.4% – Still a Buy? - Defense World
Portofino Resources (CVE:POR) Trading Up 100% – Should You Buy? - Defense World
Northern Dynasty Minerals (TSE:NDM) Stock Price Up 25% – Time to Buy? - Defense World
Northern Dynasty Minerals (TSE:NDM) Shares Up 25% – Here’s Why - Defense World
Portofino Resources (CVE:POR) Stock Price Up 100% – Time to Buy? - Defense World
Honey Badger Silver (CVE:TUF) Trading Down 12% – Here’s What Happened - Defense World
Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% – Here’s Why - Defense World
Inventiva (NASDAQ:IVA) Trading 2.7% Higher – Here’s Why - Defense World
Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Inventiva sets share repurchase program terms post-meeting - Investing.com
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright - TipRanks
Stifel maintains Buy on Inventiva shares with $17 target - Investing.com
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks
Inventiva earnings missed by $0.03, revenue topped estimates - Investing.com
Finanzdaten der Inventiva Adr-Aktie (IVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):